Opinion on Company Issues

Published within

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Bank of Queensland raises A$108m

On January 28, Bank of Queensland announced that it had managed to raise A$108m in capital. The bank secured the money by accessing a combination of benefactors comprising institutions, high net worth individuals and retail investors. The funds will push Bank of Queensland's capital ratio past 8%, and will help the bank to sustain organic growth.

Published By Datamonitor
29 Jan 2009
Expert View
Expert View

Pfizer's acquisition of Wyeth brings scale but will fail to deliver sustainable sales growth

The Pfizer-Wyeth merger will create a prescription pharmaceutical company of unprecedented scale. The combined entity would have recorded total company sales in excess of $70 billion and prescription pharmaceutical sales of over $60 billion in 2008. However, the deal is not a solution to the companies' declining sales outlooks, and profit growth will only be achieved through further cost cutting.

Published By Datamonitor
28 Jan 2009
CommentWire
CommentWire

McDonald's: capitalizing on the downturn with an even greater presence

McDonald's has announced plans to open 1,000 new restaurants in 2009, even though the recession is starting to impact on its results. The company could succeed in its gamble by encouraging more consumers to downsize to its cheaper food offering, but it must not completely forget the importance of health and premium trends.

Published By Datamonitor
27 Jan 2009
CommentWire
CommentWire

NDA: new British sites encourage foreign interest

The 2008 auction of British Energy garnered the interest of a number of foreign energy firms, ultimately leading to its acquisition by EDF. With the announcement that the Nuclear Decommissioning Authority will be selling four tracts of land suitable for new nuclear builds, the firms that lost out in the British Energy sale may still be able to enter the increasingly attractive UK nuclear market.

Published By Datamonitor
26 Jan 2009
CommentWire
CommentWire

Australia: economy teetering on the brink of recession

Fresh on the heels of discouraging unemployment data from the Australian Bureau of Statistics, several large Australian companies have announced job cuts. These cuts could prove costly for the general economy, as a high rate of employment and a relatively stable financial system were widely perceived to have shielded Australia from the worst ravages of the global economic crisis.

Published By Datamonitor
22 Jan 2009
CommentWire
CommentWire

Boutique wealth managers: a once in a lifetime opportunity

As the world's largest private banks reel from customer desertion, brand damage, staff defections and now integration problems from the mega-deals, boutique wealth managers have a unique opportunity to push their businesses forward. For those wishing to take full advantage, nothing less than a board-driven, end-to-end action plan is needed.

Published By Datamonitor
20 Jan 2009
Expert View
Expert View

Opportunity knocks for big pharmaceutical companies in the credit crunch

Although the credit crunch has left non-financial services companies, including those in the biotechnology industry, without cheap debt, the pharmaceutical industry avoided relying on this resource and has remained cash-rich. As a result, pharmaceutical companies should weather the financial storm and be able to make significant acquisitions, unlike their biotechnology counterparts.

Published By Datamonitor
09 Oct 2008
CommentWire
CommentWire

Venture Preference: announces plans to rebrand

Venture Preference, the broking arm of AXA, has announced plans to rebrand itself as Bluefin: a move which will come into full effect in January 2009. The rebranding should enable the company to build a strong brand presence in the small and medium enterprise market.

Published By Datamonitor
11 Sep 2008
Expert View
Expert View

Drug lifecycle management could be the answer to the $100 billion question

Generics are finding their way onto the drugs market with increasing ease and speed. As a result, drug lifecycle management is becoming ever more important for pharmaceutical companies looking to generate the best possible revenues from their branded products.

Published By Datamonitor
06 Aug 2008
CommentWire
CommentWire

Deutsche Postbank: long-awaited market consolidation hanging in the balance

Recent announcements in the press have pointed towards two potential deals, involving Postbank, Allianz/Dresdner, Commerzbank and Citibank Deutschland. As discussions reach more advanced stages, the moves look increasingly like they could be the trigger for the market consolidation that analysts have been predicting for some time.

Published By Datamonitor
08 Jul 2008

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

No help is available.